Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Abacus Medicine, headquartered in Denmark, is a prominent pharmaceutical company established in 2013. Operating within the pharmaceutical preparation and distribution sector, it has swiftly grown into one of Europe's leading parallel importers of original prescription medicines. The company maintains offices across key European markets, including Germany, France, the Netherlands, and the UK, serving over 20 countries.
Abacus Medicine's core business is to ensure access to high-quality, affordable prescription medicines for pharmacies and hospitals. This unique model prioritises cost-effectiveness without compromising on quality or supply reliability. With significant achievements such as reaching EUR 2bn in revenue by 2022 and becoming a leading wholesaler of medical cannabis, Abacus Medicine holds a strong market position in the European healthcare landscape.
+8 vs industry average
Abacus Medicine’s score of 50 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Abacus Medicine Climate Commitments & Emissions Overview (DK, Pharmaceutical Preparation Manufacturing)
In 2025, Abacus Medicine reported total calculated greenhouse gas emissions of approximately 1,091,179,700 kg CO2e globally. This figure includes:
For 2024, the company's global emissions were approximately 832,933,400 kg CO2e. This comprised:
Abacus Medicine also disclosed Scope 1 and 2 emissions for previous years:
Emissions data for Abacus Medicine is inherited from its parent company, Abacus Medicine A/S. The company has not publicly disclosed specific carbon reduction targets or commitments, such as those validated by the Science Based Targets initiative (SBTi).
No climate goals have been disclosed for Abacus Medicine yet.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more